ADLM Diagnostics Innovation and COVID Testing

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

ADLM Diagnostics Innovation and COVID Testing

Sector: Diagnostics
Topic: Bio Break
YouTube video thumbnail

In this Bio Break episode, Nick Allan and Nigel Syrotuck reflect on recent ADLM diagnostics innovation and how it has shaped the future of clinical testing. The Association for Diagnostics & Laboratory Medicine (ADLM) recently wrapped its annual showcase in Chicago, and as always, it left a strong impression on the medtech community.

While discussing highlights from the show, Nick and Nigel zero in on a perfect case study of ADLM diagnostics innovation: the evolution of COVID-19 testing. From the early days of enzyme-linked immunosorbent assays (ELISAs) to the familiar lateral flow tests we now perform at home, diagnostics have become faster, simpler, and more accessible. This transformation—from complex lab environments to point-of-care and even bathroom-counter diagnostics—was on full display at ADLM.

From the Lab to the Bathroom Counter

As Nick points out, one of the most remarkable shifts in diagnostics is how complicated procedures have been distilled into everyday routines. What once required trained technicians in controlled environments can now be done at home, often with little more than a test strip and a timer. The lateral flow transformation is a clear example of how ADLM’s influence and technology leadership help shape the direction of consumer-friendly diagnostics.

Sterile assurance level concept showing gloved hands opening a sterile medical device pouch with “Truly sterile?” text overlay

Nick and Nigel walk through how sterile disposables are processed and verified before they reach the field.

FDA agentic AI reviewer concept with robotic hand reviewing medical device submission documents

The FDA agentic AI is making headlines after the agency announced its own internal AI review tool. In this episode of MedDevice by Design, Ariana and Mark discuss what this could mean for medical device submissions and regulatory efficiency.

Thumbnail showing a cartoon sandwich icon with the text “Sandwich ELISA?” and a red arrow pointing to the sandwich.

The sandwich ELISA assay is one of the most common ELISA formats used in diagnostics. Nick and Nigel walk through the method step by step using simple visuals and plain language.